Collaboration on BCI Technology with Medical Institutions and Others

Ceragem announced on the 27th that it will enhance its competitiveness in future healthcare technology by leveraging the launch of the BCI (Brain-Computer Interface) Alliance.


The BCI Alliance is a collaborative platform that connects domestic BCI researchers, companies, medical institutions, and research organizations. It was launched to invigorate Korea's BCI research and industrial ecosystem, and to establish a cooperation base that spans research, clinical practice, and industrialization of related technologies.

At the "BCI Alliance Launch Ceremony" held on the 26th at The Plaza Hotel in Seoul, Kyungsoo Lee, CEO of Ceragem, and eight others are posing for a commemorative photo. Ceragem

At the "BCI Alliance Launch Ceremony" held on the 26th at The Plaza Hotel in Seoul, Kyungsoo Lee, CEO of Ceragem, and eight others are posing for a commemorative photo. Ceragem

View original image

The launch ceremony, held on the 26th at The Plaza Hotel in Seoul, was hosted by the Ministry of Science and ICT and jointly organized by the Korea BCI Association, Korea Brain Research Institute, Ybrain, and National Research Foundation of Korea. Key figures, including Lee Kyungsoo, CEO of Ceragem, and Kim Seongsu, policy chief of R&D at the Ministry of Science and ICT, attended the event.


Within the BCI Alliance, Ceragem plans to collaborate with researchers, companies, and medical institutions in related fields, explore the potential for developing new healthcare technologies utilizing BCI, and seek out new business opportunities.



A Ceragem representative stated, "BCI is a representative future technology that integrates brain science, medicine, and advanced technology," adding, "We will actively collaborate with a variety of experts to support the development of new healthcare technologies and strengthen Korea's competitiveness in the BCI sector."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing